Research News
Share:
ByJames T. Rosenbaum, MD & Marcia A. Friedman, MD

Covid Vaccines and Treatments: The Latest Guidelines and Recommendations for…

The COVID-19 pandemic, and the ever-evolving guidelines for vaccination and…

Read more
BySpondylitis Association of America

FDA Approves JAK Inhibitor Upadacitinib (Rinvoq) for Psoriatic Arthritis

A new medication has been approved by the U.S. FDA for the…

Read more
BySpondylitis Association of America

A New Biologic Medication, Bimekizumab, Shows Promise for Axial Spondyloarthritis

Bimekizumab is a first-of-its-kind dual IL-17 inhibitor that targets both IL-17A and…

Read more
BySpondylitis Association of America

New Treatment Approved for Ankylosing Spondylitis: FDA OKs First JAK…

The U.S. FDA has approved a new medication to treat…

Read more
BySpondylitis Association of America

Introducing SAA’s Primary Care and Chiropractic Initiative: Accredited Continuing Education…

SAA is rolling out two accredited continuing education programs to…

Read more
BySpondylitis Association of America

Researchers Identify Potential New Treatment Target for Axial Spondyloarthritis

Researchers at the University of Toronto in Ontario, Canada have uncovered a…

Read more
1 6 7 8 9 10 23